Finally, relevant subtypes have been described for some cancer types (e.g. BRCA and COAD) and alterations of MAPT expression could be attributed partially to the presence or prevalence of such subtypes, but this was not directly addressed in this study. This evidence concerns the gene MAPT and cancer.